Anti-RPE monoclonal antibody

Pre-made anti-RPE monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RPE/RPE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2713-Ab-1/ GM-Tg-hg-IP2713-Ab-2Anti-Human RPE monoclonal antibodyHuman
GM-Tg-rg-IP2713-Ab-1/ GM-Tg-rg-IP2713-Ab-2Anti-Rat RPE monoclonal antibodyRat
GM-Tg-mg-IP2713-Ab-1/ GM-Tg-mg-IP2713-Ab-2Anti-Mouse RPE monoclonal antibodyMouse
GM-Tg-cynog-IP2713-Ab-1/ GM-Tg-cynog-IP2713-Ab-2Anti-Cynomolgus/ Rhesus macaque RPE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2713-Ab-1/ GM-Tg-felg-IP2713-Ab-2Anti-Feline RPE monoclonal antibodyFeline
GM-Tg-cang-IP2713-Ab-1/ GM-Tg-cang-IP2713-Ab-2Anti-Canine RPE monoclonal antibodyCanine
GM-Tg-bovg-IP2713-Ab-1/ GM-Tg-bovg-IP2713-Ab-2Anti-Bovine RPE monoclonal antibodyBovine
GM-Tg-equg-IP2713-Ab-1/ GM-Tg-equg-IP2713-Ab-2Anti-Equine RPE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2713-Ab-1/ GM-Tg-hg-IP2713-Ab-2; GM-Tg-rg-IP2713-Ab-1/ GM-Tg-rg-IP2713-Ab-2;
GM-Tg-mg-IP2713-Ab-1/ GM-Tg-mg-IP2713-Ab-2; GM-Tg-cynog-IP2713-Ab-1/ GM-Tg-cynog-IP2713-Ab-2;
GM-Tg-felg-IP2713-Ab-1/ GM-Tg-felg-IP2713-Ab-2; GM-Tg-cang-IP2713-Ab-1/ GM-Tg-cang-IP2713-Ab-2;
GM-Tg-bovg-IP2713-Ab-1/ GM-Tg-bovg-IP2713-Ab-2; GM-Tg-equg-IP2713-Ab-1/ GM-Tg-equg-IP2713-Ab-2
Products NameAnti-RPE monoclonal antibody
Formatmab
Target NameRPE
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RPE monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2713-Ag-1Recombinant multi-species RPE/ RPE2-1 protein
    ORF Viral VectorpGMLP003257human RPE Lentivirus plasmid
    ORF Viral VectorvGMLP003257human RPE Lentivirus particle
    ORF Viral VectorpGMLPm000781mouse Rpe Lentivirus plasmid
    ORF Viral VectorvGMLPm000781mouse Rpe Lentivirus particle


    Target information

    Target IDGM-IP2713
    Target NameRPE
    Gene ID6120,66646,501157,711322,478893,101095761,533764,100051899
    Gene Symbol and Synonyms2810429B02Rik,5730518J08Rik,RPE,RPE2,RPE2-1
    Uniprot AccessionQ96AT9
    Uniprot Entry NameRPE_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000197713
    Target ClassificationN/A

    The target: RPE, gene name: RPE, also named as RPE2-1. Enables metal ion binding activity; protein homodimerization activity; and ribulose-phosphate 3-epimerase activity. Involved in carbohydrate metabolic process and pentose-phosphate shunt. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.